CoronaVac
Showing 1 - 25 of 94
COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)
Completed
- COVID-19
- CoronaVac/CoronaVac
- CoronaVac/BNT162b2
-
Bizerte, Mateur, Tunisia
- +4 more
Jan 4, 2023
Inactivated COVID-19 Vaccine of the First Booster Dose
Active, not recruiting
- COVID-19
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Manguinhos, BrazilInstituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ)
Jan 11, 2023
COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)
Recruiting
- COVID-19
- Vaccines
- CoronaVac®
- +2 more
-
Santiago, Metropolitana, Chile
- +2 more
Jan 12, 2023
Covid19 Trial in Hong Kong (Tozinameran, CoronaVac, CoronaVac, intradermal)
Active, not recruiting
- Covid19
- Tozinameran
- +2 more
-
Hong Kong, Hong Kong, ChinaQueen Mary Hospital
Jul 14, 2022
COVID-19 Trial in Shijiazhuang (SARS-CoV-2 Inactivated Vaccine, Placebo)
Completed
- COVID-19
- SARS-CoV-2 Inactivated Vaccine
- Placebo
-
Shijiazhuang, Hebei, ChinaZanhuang county Center for Disease Control and Prevention
Aug 10, 2022
Rheumatic Disease, HIV, AIDS Trial in São Paulo (CoronaVac)
Active, not recruiting
- Rheumatic Disease
- +5 more
- CoronaVac
-
São Paulo, SP, BrazilUniversity of Sao Paulo General Hospital
May 24, 2022
SARS-CoV Infection, Coronavirus Infection, Vaccine Adverse Reaction Trial in São Paulo (Coronavac)
Active, not recruiting
- SARS-CoV Infection
- +2 more
- Coronavac
-
São Paulo, BrazilHospital do Rim - Fundação Oswaldo Ramos
Mar 17, 2022
COVID-19 Trial in Vitória (Inactivated Coronavac/Butantan vaccine, BNT162b2 (Pfizer))
Recruiting
- COVID-19
- Inactivated Coronavac/Butantan vaccine
- BNT162b2 (Pfizer)
-
Vitória, Espírito Santo, BrazilValéria Valim
Feb 1, 2022
COVID-19 Trial in Xi'an (Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2, Inactivated SARS-CoV-2 Vaccine
Active, not recruiting
- COVID-19
- Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
- +6 more
-
Xi'an, Shanxi, ChinaYaliang county Center for Disease Control and Prevention
Dec 13, 2021
COVID-19 Trial in Xinqi (High-dosage SARS-CoV-2 vaccine, Medium-dosage SARS-CoV-2 vaccine)
Active, not recruiting
- COVID-19
- High-dosage SARS-CoV-2 vaccine
- Medium-dosage SARS-CoV-2 vaccine
-
Xinqi, Jiangsu, ChinaXinqi City Center for Disease Control and Prevention
Feb 13, 2022
COVID-19 Trial in Peshawar (Medium-dosage COVID-19 Vaccine,Inactivated, High-dosage COVID-19 Vaccine,Inactivated,
Suspended
- COVID-19
- Medium-dosage COVID-19 Vaccine,Inactivated
- +2 more
-
Peshawar, PakistanCentral Park Teaching Hospital
Aug 9, 2022
COVID-19 Trial in Huai'an (Inactivated SARS-CoV-2 Vaccine (Vero cell))
Completed
- COVID-19
- Inactivated SARS-CoV-2 Vaccine (Vero cell)
-
Huai'an, Jiangsu, ChinaJingliang Wu
Apr 12, 2022
COVID-19, Pulmonary Tuberculosis Trial in China (Standard dosage inactivated vaccine, Double dosage inactivated vaccine)
Recruiting
- COVID-19
- Pulmonary Tuberculosis
- Standard dosage inactivated vaccine
- Double dosage inactivated vaccine
-
Huai'an, Jiangsu, China
- +5 more
Aug 12, 2022
COVID-19 Pandemic Trial in Shaoguan (V-01D-351, CoronaVac)
Active, not recruiting
- COVID-19 Pandemic
- V-01D-351
- CoronaVac
-
Shaoguan, Guangdong, ChinaShaoguan Hospital of Chinese Medicine
Oct 16, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, CoronaVac, Sinopharm inactivated COVID-19 vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E
- +3 more
- (no location specified)
Apr 1, 2022
COVID-19 Trial in Beijing (High-dosage of COVID-19 vaccine (Vero cell), Inactivated, Medium-dose COVID-19 Vaccine(Vero
Completed
- COVID-19
- High-dosage of COVID-19 vaccine (Vero cell), Inactivated
- Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated
-
Beijing, Beijing, ChinaBeijing Youan Hospital Capital Medical University
Aug 9, 2022
SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA vaccine (RBMRNA)
- CoronaVac®
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
COVID-19 Trial in Hangzhou (Recombinant novel coronavirus vaccine (CHO cells))
Active, not recruiting
- COVID-19
- Recombinant novel coronavirus vaccine (CHO cells)
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial Center for Disease Control and Prevention
Jan 11, 2022
COVID-19, Cancer Trial in Ratchathewi (CoronaVac vaccine)
Completed
- COVID-19
- Cancer
- CoronaVac vaccine
-
Ratchathewi, Bangkok, ThailandNational Cancer Institute
Apr 9, 2022
COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,
Recruiting
- COVID-19 Pandemic
- COVID-19 Vaccines
- Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
- CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
-
Surabaya, East Java, IndonesiaDr. Soetomo General Hospital
Jun 21, 2023
COVID-19 Vaccination Trial in Hong Kong (BNT162b2, CoronaVac)
Active, not recruiting
- COVID-19 Vaccination
- BNT162b2
- CoronaVac
-
Hong Kong, Hong KongThe University of Hong Kong
Feb 8, 2022
COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)
Not yet recruiting
- COVID-19 SARS-CoV-2 Infection
- CoronaVac
- SCTV01E
- (no location specified)
Jan 4, 2023
COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)
Active, not recruiting
- COVID-19
- Inactivated COVID-19 Vaccine
-
Weihai, Shandong, ChinaRushan City Center for Disease Control and Prevention
Jul 11, 2022
COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)
Recruiting
- COVID-19
- Inactivated COVID-19 Vaccine
-
Weihai, Shandong, ChinaRushan City Center for Disease Control and Prevention
Jan 19, 2022
Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,
Recruiting
- COVID-19
- ChAdOx1 nCOV-19 vaccine (Vaxzeria)
- +3 more
-
São Paulo, BrazilTechtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023